Non-genetic risk factors in haemophilia A inhibitor management - the danger theory and the use of animal models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-genetic risk factors in haemophilia A inhibitor management - the danger theory and the use of animal models

Published:2016-08-26 Issue:5 Volume:22 Page:657-666
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Lövgren K. M.¹²,Søndergaard H.³,Skov S.¹,Wiinberg B.⁴

Affiliation:

1. Department of Veterinary Disease Biology; University of Copenhagen; Frederiksberg Denmark

2. Translational Haemophilia Pharmacology, Global Research; Novo Nordisk A/S; Maaloev Denmark

3. Diabetes Complications Pharmacology; Global Research; Novo Nordisk A/S; Maaloev Denmark

4. Haemophilia Translational Biology, Global Research; Novo Nordisk A/S; Maaloev Denmark

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13075/fullpdf

Reference83 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia,2013

2. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis;White;Thromb Haemost,2001

3. Arthropathy in children with severe hemophilia A;Soreff;Acta Paediatr Scand,1980

4. Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II);Kavakli;J Thromb Haemost,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between mutations in severe hemophilia A and risk of inhibitor development: A large single-center study;Transfusion and Apheresis Science;2024-12

2. A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial;Blood Advances;2024-03-15

3. Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication;Blood Advances;2023-04-28

4. Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report;International Journal of Hematology;2022-05-09

5. Hemophilia: The Past, the Present, and the Future;Pediatrics In Review;2021-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3